Investor directory

SEED

SEED is a Japanese company specializing in the manufacturing and sale of eye care products, particularly contact lenses and glasses frames. The company has developed a range of products, including daily disposable lenses such as SEED 1dayPure and SEED Fine disposable lenses, as well as high oxygen permeability hard contact lenses known as SEED S-1. Through its innovative technologies and commitment to quality, SEED has earned customer trust in the eye care market.

Top Stages

Acquisition
http://www.seed.co.jp
https://crunchbase.com/organization/seed-ddab
https://pitchbook.com/profiles/company/170371-90
https://twitter.com/seed_koho

Masahiro Urakabe

CEO and President

1 past transactions

SENSIMED

Acquisition in 2019
Sensimed AG is a medical devices company based in Lausanne, Switzerland, founded in 2003. The company specializes in the design, development, and commercialization of integrated micro-systems for medical applications, particularly focusing on glaucoma management. Its flagship product, the SENSIMED Triggerfish, is a soft, single-use contact lens that enables continuous monitoring of intraocular pressure (IOP) fluctuations in glaucoma patients over a 24-hour period. The Triggerfish system includes disposable sensors, an adhesive antenna for communication, a battery-powered recorder for data collection, and software for data management and analysis. Sensimed aims to enhance personalized treatment for glaucoma patients by analyzing the collected data to identify pathological patterns and improve clinical outcomes. The company's products are distributed through partners across Europe, Asia-Pacific, the Middle East, and the Americas. As of December 2019, Sensimed operates as a subsidiary of SEED Co., Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.